


{"id":54431,"date":"2025-03-17T14:13:04","date_gmt":"2025-03-17T12:13:04","guid":{"rendered":"https:\/\/www.fyb.de\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/"},"modified":"2025-03-17T14:13:04","modified_gmt":"2025-03-17T12:13:04","slug":"bayern-kapital-invests-in-vantis-with-growth-fund-2","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/","title":{"rendered":"Bayern Kapital invests in Vantis with Growth Fund&nbsp;2"},"content":{"rendered":"<p>Landshut\/Munich \u2014 Bayern Kapi\u00adtal, the venture and growth capi\u00adtal company of the Free State of Bava\u00adria, is inves\u00adt\u00ading in Vantis, an inno\u00adva\u00adtive provi\u00adder of hybrid care for chro\u00adni\u00adcally ill pati\u00adents using digi\u00adtal solu\u00adti\u00adons in combi\u00adna\u00adtion with regu\u00adlar visits to the doctor, through its Bayern 2 growth fund. \u2014 Twip Impact Ventures and the exis\u00adting inves\u00adtors first\u00admi\u00adnute capi\u00adtal and b2venture are also parti\u00adci\u00adpa\u00adting in the Series A finan\u00adcing round led by Ange\u00adlini Ventures in the double-digit million range.&nbsp;<\/p>\n<p>The funds from the finan\u00adcing round will prima\u00adrily be used to further expand the team and the data-driven, proac\u00adtive manage\u00adment of chro\u00adni\u00adcally ill pati\u00adents, as well as to expand the network of GP prac\u00adti\u00adces opera\u00adted by Vantis.<\/p>\n<p>When caring for pati\u00adents with chro\u00adnic illnesses, such as cardio\u00advas\u00adcu\u00adlar dise\u00ada\u00adses, it is important to provide regu\u00adlar outpa\u00adti\u00adent care and acute emer\u00adgency care as well as conti\u00adnuous long-term care and support for pati\u00adents in their ever\u00ady\u00adday lives, ideally tail\u00ado\u00adred to their indi\u00advi\u00addual needs. The latter in parti\u00adcu\u00adlar are often complex and require conti\u00adnuous moni\u00adto\u00adring of the pati\u00aden\u00adt\u2019s state of health and vital signs. At the same time, the demand for appro\u00adpriate care is conti\u00adnuously incre\u00adasing as demo\u00adgra\u00adphic change progres\u00adses, while a shortage of doctors is threa\u00adtening to lead to a lack of care, parti\u00adcu\u00adlarly in rural regi\u00adons. Hubert Aiwan\u00adger (Bava\u00adrian Minis\u00adter of Econo\u00admic Affairs) explains: \u201cDemo\u00adgra\u00adphic change and the resul\u00adting increase in the number of chro\u00adnic illnesses in the popu\u00adla\u00adtion means that inno\u00adva\u00adtive approa\u00adches are needed for the health\u00adcare system. With its combi\u00adna\u00adtion of digi\u00adtal and perso\u00adnal care, Vantis shows what such inno\u00adva\u00adtions can look like. The company is a good exam\u00adple of a Bava\u00adrian company that is successful on the market as a \u2018first mover\u2019 with a future-proof busi\u00adness model. It demons\u00adtra\u00adtes the inno\u00adva\u00adtive strength and future viabi\u00adlity of the Bava\u00adrian tech\u00adno\u00adlogy sector.\u201d&nbsp;<\/p>\n<p><strong>Vantis addres\u00adses the chall\u00adenge of under\u00adsup\u00adply in particular.<\/strong><\/p>\n<p>The company has set itself the goal of ensu\u00adring opti\u00admal care and making it simp\u00adler and more effi\u00adci\u00adent for pati\u00adents and doctors. Foun\u00added in 2019, the company combi\u00adnes inno\u00adva\u00adtive digi\u00adtal treat\u00adment methods such as tele\u00adme\u00addi\u00adcine, data-driven remote moni\u00adto\u00adring and support from arti\u00adfi\u00adcial intel\u00adli\u00adgence (AI) with tail\u00ado\u00adred, pati\u00adent-cente\u00adred care from GPs to create digi\u00adtal long-term therapy for chro\u00adni\u00adcally ill patients.&nbsp;<\/p>\n<p>\u201cThe digi\u00adtal trans\u00adfor\u00adma\u00adtion of the health\u00adcare system requi\u00adres considera\u00adble invest\u00adment to ensure that ever\u00adyone bene\u00adfits in the end \u2014 doctors, pati\u00adents and payers. As a digi\u00adtal health\u00adcare company with our own prac\u00adti\u00adces, we have the unique oppor\u00adtu\u00adnity to tailor our tech\u00adno\u00adlogy to the current and future chal\u00adlenges in GP care and to conti\u00adnuously opti\u00admize it. Our goal is to achieve better treat\u00adment outco\u00admes for pati\u00adents and to make doctors\u2019 ever\u00ady\u00adday work easier so that they can focus more on medi\u00adcal care,\u201d says<strong> Till Jansen, CEO of Vantis<\/strong>.<\/p>\n<p>\u201cWe invest in young compa\u00adnies that are prepared to chall\u00adenge the status quo and bring inno\u00adva\u00adtions to the market. With the combi\u00adna\u00adtion of its own GP prac\u00adti\u00adces and comple\u00admen\u00adtary digi\u00adtal health appli\u00adca\u00adti\u00adons, Vantis is pursuing the goal of sustain\u00adably impro\u00adving GP care for doctors and pati\u00adents. This forward-looking stra\u00adtegy makes Vantis a promi\u00adsing invest\u00adment for us. The company offers a solu\u00adtion that is in tune with the times and addres\u00adses the growing requi\u00adre\u00adments in the health\u00adcare market. In addi\u00adtion, Vantis has a diver\u00adsi\u00adfied, solid busi\u00adness model and attrac\u00adtive growth pros\u00adpects,\u201d says<strong> Monika Steger (photo), Co-Mana\u00adging Direc\u00adtor of Bayern Kapi\u00adtal<\/strong>.<\/p>\n<p><strong>About Vantis<\/strong><\/p>\n<p>Vantis is a Munich-based company and a pioneer in digi\u00adtal health\u00adcare. The company addres\u00adses one of the biggest chal\u00adlenges in the German health\u00adcare system: more pati\u00adents, fewer doctors. Through the targe\u00adted use of digi\u00adtal tech\u00adno\u00adlo\u00adgies and inno\u00adva\u00adtive treat\u00adment methods, Vantis combi\u00adnes the best of medi\u00adcine, tech\u00adno\u00adlogy and effi\u00adci\u00adent prac\u00adtice orga\u00adniza\u00adtion. To this end, Vantis is inves\u00adt\u00ading in its own network of gene\u00adral medi\u00adcal prac\u00adti\u00adces to ensure compre\u00adhen\u00adsive, future-proof medi\u00adcal care. www.vantis-health.com\/de\/    <\/p>\n<p><strong>About Bayern Kapital<\/strong><\/p>\n<p>Bayern Kapi\u00adtal GmbH, based in Lands\u00adhut, is the venture\/growth capi\u00adtal company of the Free State of Bava\u00adria. It supports inno\u00adva\u00adtive high-tech and deep-tech compa\u00adnies in Bava\u00adria through various growth phases, from seed to later stage, with equity capi\u00adtal of EUR 0.25 to 25 million. Bayern Kapi\u00adtal often closes gaps in the VC sector in proven consor\u00adtium constel\u00adla\u00adti\u00adons with private investors.&nbsp;<\/p>\n<p>Bayern Kapi\u00adtal mana\u00adges specia\u00adli\u00adzed invest\u00adment funds with a volume of around 700 million euros. Since its foun\u00adda\u00adtion in 1995, the wholly-owned subsi\u00addiary of LfA F\u00f6rder\u00adbank Bayern has inves\u00adted over 500 million euros of its own equity capi\u00adtal in more than 320 start-ups and scale-ups from sectors such as life scien\u00adces, soft\u00adware &amp; IT, mate\u00adri\u00adals &amp; new mate\u00adri\u00adals, nano\u00adtech\u00adno\u00adlogy and envi\u00adron\u00admen\u00adtal tech\u00adno\u00adlogy. This has crea\u00adted over 10,000 perma\u00adnent jobs in sustainable compa\u00adnies in Bava\u00adria. The active port\u00adfo\u00adlio curr\u00adently compri\u00adses almost 100 companies.<\/p>\n<p>Examp\u00adles of nume\u00adrous ground\u00adbrea\u00adking success stories that Bayern Kapi\u00adtal has been invol\u00adved in at an early stage include EOS (today the worl\u00add\u2019s leading tech\u00adno\u00adlogy provi\u00adder in indus\u00adtrial 3D prin\u00adting of metals and plas\u00adtics), Proglove, Fazua, SimS\u00adcale, Scom\u00adpler, egym, Parcel\u00adlab, Cobrai\u00adner, Quan\u00adtum Systems, Casavi, Riskme\u00adthods, Tubu\u00adlis, Cata\u00adlym, Immu\u00adnic, Sirion, tado and many more. www.bayernkapital.de<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Landshut\/Munich \u2014 Bayern Kapi\u00adtal, the venture and growth capi\u00adtal company of the Free State of Bava\u00adria, is inves\u00adt\u00ading in Vantis, an inno\u00adva\u00adtive provi\u00adder of hybrid care for chro\u00adni\u00adcally ill pati\u00adents using digi\u00adtal solu\u00adti\u00adons in combi\u00adna\u00adtion with regu\u00adlar visits to the doctor, through its Bayern 2 growth fund. \u2014 Twip Impact Ventures and the exis\u00adting investors&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":54429,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[1366],"tags":[],"class_list":["post-54431","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Bayern Kapital invests in Vantis with Growth Fund 2 - FYB Financial Yearbook<\/title>\n<meta name=\"description\" content=\"Landshut\/Munich - Bayern Kapital, the venture and growth capital company of the Free State of Bavaria, is investing in Vantis, an innovative provider of hybrid care for chronically ill patients using digital solutions in combination with regular visits to the doctor, through its Bayern 2 growth fund. - Twip Impact Ventures and existing investors firstminute capital and b2venture are also participating in the double-digit million Series A round led by Angelini Ventures.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bayern Kapital invests in Vantis with Growth Fund 2 - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Landshut\/Munich - Bayern Kapital, the venture and growth capital company of the Free State of Bavaria, is investing in Vantis, an innovative provider of hybrid care for chronically ill patients using digital solutions in combination with regular visits to the doctor, through its Bayern 2 growth fund. - Twip Impact Ventures and existing investors firstminute capital and b2venture are also participating in the double-digit million Series A round led by Angelini Ventures.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-17T12:13:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/bayernkapital-monika-steger-bayernkapital-kopie-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"1274\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"Bayern Kapital invests in Vantis with Growth Fund&nbsp;2\",\"datePublished\":\"2025-03-17T12:13:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/\"},\"wordCount\":830,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/bayernkapital-monika-steger-bayernkapital-kopie-scaled.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/\",\"url\":\"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/\",\"name\":\"Bayern Kapital invests in Vantis with Growth Fund 2 - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/bayernkapital-monika-steger-bayernkapital-kopie-scaled.jpg\",\"datePublished\":\"2025-03-17T12:13:04+00:00\",\"description\":\"Landshut\/Munich - Bayern Kapital, the venture and growth capital company of the Free State of Bavaria, is investing in Vantis, an innovative provider of hybrid care for chronically ill patients using digital solutions in combination with regular visits to the doctor, through its Bayern 2 growth fund. - Twip Impact Ventures and existing investors firstminute capital and b2venture are also participating in the double-digit million Series A round led by Angelini Ventures.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/bayernkapital-monika-steger-bayernkapital-kopie-scaled.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/bayernkapital-monika-steger-bayernkapital-kopie-scaled.jpg\",\"width\":2048,\"height\":1274,\"caption\":\"Monika Steger, Gesch\u00e4ftsf\u00fchrerin von Bayern Kapital \u00a9 bayern kapital\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bayern Kapital invests in Vantis with Growth Fund&nbsp;2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bayern Kapital invests in Vantis with Growth Fund 2 - FYB Financial Yearbook","description":"Landshut\/Munich - Bayern Kapital, the venture and growth capital company of the Free State of Bavaria, is investing in Vantis, an innovative provider of hybrid care for chronically ill patients using digital solutions in combination with regular visits to the doctor, through its Bayern 2 growth fund. - Twip Impact Ventures and existing investors firstminute capital and b2venture are also participating in the double-digit million Series A round led by Angelini Ventures.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/","og_locale":"en_US","og_type":"article","og_title":"Bayern Kapital invests in Vantis with Growth Fund 2 - FYB Financial Yearbook","og_description":"Landshut\/Munich - Bayern Kapital, the venture and growth capital company of the Free State of Bavaria, is investing in Vantis, an innovative provider of hybrid care for chronically ill patients using digital solutions in combination with regular visits to the doctor, through its Bayern 2 growth fund. - Twip Impact Ventures and existing investors firstminute capital and b2venture are also participating in the double-digit million Series A round led by Angelini Ventures.","og_url":"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2025-03-17T12:13:04+00:00","og_image":[{"width":2048,"height":1274,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/bayernkapital-monika-steger-bayernkapital-kopie-scaled.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"Bayern Kapital invests in Vantis with Growth Fund&nbsp;2","datePublished":"2025-03-17T12:13:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/"},"wordCount":830,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/bayernkapital-monika-steger-bayernkapital-kopie-scaled.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/","url":"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/","name":"Bayern Kapital invests in Vantis with Growth Fund 2 - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/bayernkapital-monika-steger-bayernkapital-kopie-scaled.jpg","datePublished":"2025-03-17T12:13:04+00:00","description":"Landshut\/Munich - Bayern Kapital, the venture and growth capital company of the Free State of Bavaria, is investing in Vantis, an innovative provider of hybrid care for chronically ill patients using digital solutions in combination with regular visits to the doctor, through its Bayern 2 growth fund. - Twip Impact Ventures and existing investors firstminute capital and b2venture are also participating in the double-digit million Series A round led by Angelini Ventures.","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/bayernkapital-monika-steger-bayernkapital-kopie-scaled.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2025\/03\/bayernkapital-monika-steger-bayernkapital-kopie-scaled.jpg","width":2048,"height":1274,"caption":"Monika Steger, Gesch\u00e4ftsf\u00fchrerin von Bayern Kapital \u00a9 bayern kapital"},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/bayern-kapital-invests-in-vantis-with-growth-fund-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"Bayern Kapital invests in Vantis with Growth Fund&nbsp;2"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/54431","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=54431"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/54431\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/54429"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=54431"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=54431"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=54431"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}